Sociodemographic variables |
Sociodemographic
variables |
Sociodemographic variables |
Sociodemographic variables |
Sociodemographic
variables |
Sociodemographic variables |
Age (aƱos) [mean (SD)] |
80 (10) |
0 (0%) |
80.6 (9.5) |
79.2 (9.5) |
<0.001 |
Female sex [n (%)] |
7473 (55.5) |
0 (0%) |
4023 (52.5) |
3450
(59.6) |
<0.001 |
Variables of comorbidity |
Variables of comorbidity |
Variables of comorbidity |
Variables of comorbidity |
Variables of comorbidity |
Variables of
comorbidity |
Arterial hypertension [n (%)] |
11228 (83.6) |
23 (0.2%) |
6525
(85.2) |
4703 (81.4) |
<0.001 |
Diabetes mellitus [n (%)] |
5662 (42.2) |
24 (0.2%) |
3696 (48.3) |
1966 (34) |
<0.001 |
Dyslipemia [n (%)] |
5773 (43) |
24 (0.2%) |
3452 (45.1) |
2321
(40.2) |
<0.001 |
Ischemic heart disease [n (%)] |
3933 (29.3) |
25 (0.2%) |
2474
(32.3) |
1459 (25.3) |
<0.001 |
Heart valve disease [n (%)] |
3549 (26.4) |
24 (0.2%) |
2166
(28.3) |
1383 (23.9) |
<0.001 |
Atrial fibrillation [n (%)] |
6560 (48.8) |
24 (0.2%) |
3766
(49.2) |
2794 (48.4) |
0.33 |
Chronic kidney disease [n (%)] |
3390 (25.2) |
22 (0.2%) |
2479
(32.4) |
911 (15.8) |
<0.001 |
Cerebrovascular disease [n (%)] |
1712 (12.7) |
24 (0.2%) |
1080
(14.1) |
632 (10.9) |
<0.001 |
COPD [n (%)] |
3229 (24.1) |
31 (0.2%) |
1942 (25.4) |
1287 (22.3) |
<0.001 |
Peripheral artery disease [n (%)] |
1205 (9) |
26 (0.2%) |
814
(10.6) |
391 (6.8) |
<0.001 |
Previous episode of HF [n (%)] |
7973 (60.3) |
222 (1.7%) |
4854
(64.3) |
3119 (54.9) |
<0.001 |
Basal status |
|
|
|
|
|
Basal NYHA III-IV [n (%)] |
3129 (24.8) |
835 (6.2%) |
1927 (26.7) |
1202 (22.2) |
<0.001 |
Barthel < 60 points [n (%)] |
2236 (18.8) |
1542 (11.5%) |
1406 (20.7) |
830 (16.3) |
<0.001 |
Treatment prior to emergency department care |
Treatment prior to emergency department care |
Treatment prior to emergency department care |
Treatment prior to emergency department care |
Treatment prior to emergency department care |
Treatment prior to emergency department care |
Loop diuretics [n (%)] |
8663 (66.4) |
398 (3%) |
5255 (70.5) |
3408 (60.9) |
<0.001 |
Potassium sparing diuretics [n (%)] |
2239 (17.2) |
400 (3%) |
1338 (17.9) |
901 (16.1) |
0.005 |
Thiazide diuretics [n (%)] |
1836 (14.1) |
401 (3%) |
1024 (13.7) |
812 (14.2) |
0.22 |
Beta- blockers [n (%)] |
5283 (40.5) |
404 (3%) |
3081 (41.1) |
2202 (39.3) |
0.019 |
ACE inhibitors [n (%)] |
4380 (33.6) |
400 (3%) |
2495 (33.5) |
1885 (33.7) |
0.82 |
ARBs [n (%)] |
3241 (24.8) |
402 (3%) |
1873 (25.1) |
1368 (24.4) |
0.35 |
Oral anticoagulation [n (%)] |
2551 (19.5) |
401 (3%) |
1490 (20) |
1061 (18.9) |
0.14 |
Antiaggregants [n (%)] |
4911 (37.6) |
401 (3%) |
2997 (40.2) |
1914 (34.2) |
<0.001 |
Digoxin [n (%)] |
2113 (16.2) |
412 (3.1%) |
1134 (15.2) |
979
(17.5) |
0.001 |
Amiodarone [n (%)] |
804 (6.2) |
406 (3%) |
307 (5.5) |
497 (6.7) |
0.005 |
Nitrates [n (%)] |
2349 (18) |
403 (3%) |
1534 (20.6) |
815 (14.6) |
<0.001 |
Statins [n (%)] |
4584 (42.1) |
2567 (19.1%) |
2771 (44.5) |
1813
(38.9) |
<0.001 |
Clinical data of the acute episode |
|
|
|
|
|
Heart rate > 100 bpm [n(%)] |
3314 (25.3) |
335
(2.5%) |
1575 (21.1) |
1739 (30.8) |
<0.001 |
Respiratory rate > 20 rpm [n(%)] |
4597 (49.4) |
4149
(30.8%) |
2645 (49.3) |
1952 (49.6) |
0.76 |
SBP (mmHg) [mean (SD)] |
141.3 (27.9) |
226 (1.7%) |
140.3 (28,0) |
142.7 (27.8) |
<0.001 |
DBP (mmHg) [mean (SD)] |
76.3 (17.5) |
237 (1.8%) |
73.5 (17.4) |
79.9 (17.4) |
<0.001 |
SatO2 < 90% [n(%)] |
2956 (22.9) |
546 (4.1%) |
1637
(22.2) |
1319 (23.8) |
0.03 |
NYHA episode III-IV [n (%)] |
11553 (89.1) |
493 (3.7%) |
6666
(90.1) |
4887 (87.9) |
<0.001 |